Synapse E Gyan May 18

25 Questions | Total Attempts: 92

SettingsSettingsSettings
Synapse E Gyan May 18 - Quiz

. Welcome to TE E-GYAN Test Here is an opportunity to test your Product knowledge and Strategy. You have 20 minutes to complete this test. Please enter your Name , Emp. Code ,HQ and Select your state. Then press "Start" to begin the test. You can only attend the test once and hence make sure you have uninterrupted internet connectivity. All the best Micro Leadership Academy


Questions and Answers
  • 1. 
    Nicergoline blocks
    • A. 

      Beta receptor

    • B. 

      Serotonoin receptor

    • C. 

      Alpha 1 adrenoreceptor

    • D. 

      GABA receptor

  • 2. 
    Nicergoline is in clinical use for 
    • A. 

      over 3 decades 

    • B. 

      1 Decade

    • C. 

      2 Years

    • D. 

      6 Month

  • 3. 
    The DCGI approved indications of Nicergoline are 
    • A. 

      Acute & Chronic Peripheral & Cerebral Vascular metabolic disorders

    • B. 

      Raynaud's Syndrome

    • C. 

      All syndromes due to altered peripheral flow

    • D. 

      All of the above

  • 4. 
    The dose of Nicerbium is 
    • A. 

      30 mg OD

    • B. 

      30 mg TID

    • C. 

      30 mg BD

    • D. 

      30 mg QID

  • 5. 
    The punch line of Nicerbium is 
    • A. 

      Reintegrates mood

    • B. 

      Reintegrates life

    • C. 

      Improves cognition

    • D. 

      Improves behaviour

  • 6. 
    Nicerbium shows positive effects on 
    • A. 

      Cognition

    • B. 

      Behaviour

    • C. 

      Both

    • D. 

      None of the above

  • 7. 
    Nicerbium has to be promoted to 
    • A. 

      All Neurologists

    • B. 

      All Neurosurgeons

    • C. 

      Psychiatrists

    • D. 

      All of the Above

  • 8. 
    Nicergoline increases utilization of 
    • A. 

      Glucose

    • B. 

      Oxygen

    • C. 

      Both

    • D. 

      None

  • 9. 
    Nicergoline offers 
    • A. 

      Antioxidant properties

    • B. 

      Antidepressants action

    • C. 

      Anxiolytic properties

    • D. 

      None of the above

  • 10. 
    Nicerbium is used in 
    • A. 

      Dementia of Alzheimer's type

    • B. 

      Diabetes

    • C. 

      Anxiety

    • D. 

      Hypertension

  • 11. 
    The Raw material of Nicergoline is imported from 
    • A. 

      Astrazeneca US

    • B. 

      Teva Pharmaceuticals Israel

    • C. 

      Pfizer US

    • D. 

      None of the above

  • 12. 
    As per Biomed Research International , Nicergoline is used in 
    • A. 

      10 Countries

    • B. 

      50 Countries

    • C. 

      70 Countries

    • D. 

      80 Countries

  • 13. 
    Which Journal has proven the efficacy of Nicergoline in Dementia ?
    • A. 

      AMJ

    • B. 

      JAMA

    • C. 

      IMJ

    • D. 

      BMJ

  • 14. 
    Nicerbium can also be used in 
    • A. 

      Vertigo

    • B. 

      High Fever

    • C. 

      Headache

    • D. 

      Migraine

  • 15. 
    Nicergoline is Potent 
    • A. 

      Vinpocetine derivative

    • B. 

      Ergot derivative

    • C. 

      Clove oil derivative

    • D. 

      None of the above

  • 16. 
    Nicerbium offers 
    • A. 

      Neuroprotective action

    • B. 

      Antithrombotic activity

    • C. 

      Both

    • D. 

      None

  • 17. 
    For better results, Nicerbium has to be used for 
    • A. 

      6 Month

    • B. 

      12 Month

    • C. 

      3 Month

    • D. 

      6 Years

  • 18. 
    As per Psychopharmacology, Nicerbium
    • A. 

      Improves Vigilance

    • B. 

      Improves information procession

    • C. 

      Both

    • D. 

      None

  • 19. 
    As per Clinical drug investigation
    • A. 

      Nicerbium induces Vasoconstriction

    • B. 

      Nicerbium induces Vasodilation

    • C. 

      Both

    • D. 

      None

  • 20. 
    As per Clinical drug investigation, the % of improvement in balance disorder is 
    • A. 

      44-78 %

    • B. 

      44-56%

    • C. 

      55-80%

    • D. 

      50-85%

  • 21. 
    As per Clinical drug investigation, Nicerbium shows improvements in
    • A. 

      Recent memory

    • B. 

      Cerebral infarction

    • C. 

      Hypobulia

    • D. 

      All of the Above

  • 22. 
    As per Biomed Research International , Nicergoline is safe agent for 
    • A. 

      Cognitive Function Disorders

    • B. 

      Epilepsy

    • C. 

      Depression

    • D. 

      Neuropathic pain

  • 23. 
    Which of the following is not an indication of Nicerbium
    • A. 

      Cerebral infarction

    • B. 

      Acute & Chronic Peripheral & Cerebral Vascular metabolic disorders

    • C. 

      Vascular dementia & Alzheimer's disease

    • D. 

      Hypertension

  • 24. 
    The story line of Nicerbium in Psy page of Visual Aid
    • A. 

      Vascular Cognitive Impairment .. Interrupts social & occupational functioning

    • B. 

      Vascular Cognitive Impairment .. Disrupts social functioning

    • C. 

      Rediscover life

    • D. 

      For better social and occupational fucntioning

  • 25. 
    The story line of Nicerbium in Neuro page of Visual Aid
    • A. 

      Vascular Cognitive Impairment .. Interrupts social & occupational functioning

    • B. 

      Vascular Cognitive Impairment .. Disrupts social functioning

    • C. 

      Rediscover life

    • D. 

      For better social and occupational fucntioning

Back to Top Back to top